Quest Diagnostics Inc (DGX.N): 2Q26 Quick Take: Utilization Remains Healthy; Solid Beat and Raise-20260723

2Q26 Results — 2Q26 revenue of $3.04bn beat FactSet consensus of $2.97bn and reflects ~10.2% Y/Y growth. Revenue in the quarter was driven by Diagnostic Information Services growing +10.3% Y/Y with revenue of $2.98bn (vs VA consensus of $2.91bn). Revenue per requisition saw (2.8%) Y/Y decline, as expected given Fresenius and Corewell integrations, offset by requisition volume growing +13.1% Y/Y (+13.0% Y/Y organic requisition volume growth). Adj. OPM of 16.5% landed slightly below consensus of ~16.7% and le ...

Quest Diagnostics Inc (DGX.N): 2Q26 Quick Take: Utilization Remains Healthy; Solid Beat and Raise-20260723 - Reportify